{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:16:15Z","timestamp":1790090175835,"version":"4.0.1"},"reference-count":332,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116628","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:26:17Z","timestamp":1775809577000},"page":"116628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The cGAS-STING-Glymphatic-gut Axis in Parkinson's disease: A proposed self-amplifying triad of Neuroinflammation and therapeutic opportunity"],"prefix":"10.1016","volume":"179","author":[{"given":"Ahmed M.","family":"Abdelaziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116628_bb0005","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinsons disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb0010","article-title":"Canagliflozin attenuates neurodegeneration and ameliorates dyskinesia through targeting the NLRP3\/Nurr1\/GSK-3\u03b2\/SIRT3 pathway and autophagy modulation in rotenone-lesioned rats","volume":"146","author":"Abdelaziz","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of parkinsons disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0020","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of parkinsons disease: a special essay on the 200th anniversary of the shaking palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156983","article-title":"GDF15 upregulation in parkinsons disease: compensatory mechanisms and causal insights","volume":"193","author":"Alshahrani","year":"2025","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2026.116628_bb0030","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.3390\/ijms262211207","article-title":"Neurodegeneration as ecosystem failure: a new paradigm for prevention and treatment","volume":"26","author":"Velikic","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/ejn.14290","article-title":"Immune system responses in parkinsons disease: early and dynamic","volume":"49","author":"Tansey","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111349","article-title":"Glutamatergic dysfunction in neurodegenerative diseases focusing on parkinsons disease: role of glutamate modulators","volume":"225","author":"Almohmadi","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2026.116628_bb0050","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for parkinsons disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the braak staging scheme for parkinsons disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and non-motor features of parkinsons disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0065","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1136\/gutjnl-2023-329685","article-title":"Gastrointestinal syndromes preceding a diagnosis of parkinsons disease: testing braaks hypothesis using a nationwide database for comparison with alzheimers disease and cerebrovascular diseases","volume":"72","author":"Konings","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2026.116628_bb0070","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/ene.13919","article-title":"Prevalence and duration of non-motor symptoms in prodromal parkinsons disease","volume":"26","author":"Durcan","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring braaks hypothesis of parkinsons disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0080","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.3390\/ijms24087205","article-title":"Gut-to-brain \u03b1-Synuclein transmission in parkinsons disease: evidence for prion-like mechanisms","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/v13071394","article-title":"The neural gut\u2013brain axis of pathological protein aggregation in Parkinson\u2019s disease and its counterpart in peroral prion infections","volume":"13","author":"Beekes","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2026.116628_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first parkinsons disease: an update on recent evidence","volume":"122","author":"Horsager","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and neuroinflammation in parkinsons disease: a self-sustained loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.intimp.2026.116628_bb0100","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/brain\/awaa293","article-title":"Body-first versus brain-first biological subtyping of parkinsons disease","volume":"143","author":"Bohnen","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2026.116628_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2025.08.051","article-title":"Advancing nanotheranostics for neuro-immunological disorders: current status and future prospects","volume":"585","author":"Rai","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2026.116628_bb0110","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.2147\/JIR.S468609","article-title":"Novel insights into Parkin-mediated mitochondrial dysfunction and \u201cMito-inflammation\u201d in \u03b1-Synuclein toxicity. The role of the cGAS-STING signalling pathway","volume":"17","author":"G\u0105ssowska-Dobrowolska","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb0115","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/hmg\/ddad062","article-title":"Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT","volume":"32","author":"Al Khatib","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.intimp.2026.116628_bb0120","article-title":"Signaling by cGAS-STING in neurodegeneration, Neuroinflammation and Aging","volume":"44","author":"Paul","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118819119","article-title":"STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy","volume":"119","author":"Hinkle","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116628_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-025-02203-9","article-title":"The glymphatic system in neurodegenerative diseases and brain tumors: mechanistic insights, biomarker advances, and therapeutic opportunities","volume":"14","author":"Jia","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2026.116628_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/NRR.NRR-D-24-00764","article-title":"Targeting the glymphatic system to promote \u03b1-synuclein clearance: a novel therapeutic strategy for parkinsons disease","volume":"21","author":"Lian","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb0140","first-page":"4519","article-title":"The influence of the glymphatic system on \u03b1-synuclein propagation: the role of aquaporin-4","volume":"148","author":"Lopes","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2026.116628_bb0145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82232","article-title":"Loss of aquaporin-4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation","volume":"12","author":"Gomolka","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2026.116628_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-025-03563-8","article-title":"CGAS-STING signaling in brain aging and neurodegeneration: molecular links and therapeutic perspectives","volume":"22","author":"Li","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116628_bb0155","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mdc3.70029","article-title":"The gut-brain axis in parkinson disease: emerging concepts and therapeutic implications","volume":"12","author":"Menozzi","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41531-025-00909-0","article-title":"Association of glymphatic system function with peripheral inflammation and motor symptoms in Parkinson\u2019s disease","volume":"11","author":"Lin","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0165","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4103\/1673-5374.391312","article-title":"Glymphatic system: a gateway for neuroinflammation","volume":"19","author":"Zou","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb0170","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/brainsci15111241","article-title":"The cGAS\u2013STING pathway in dementia: an emerging mechanism of neuroinflammation","volume":"15","author":"Min","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27020928","article-title":"The glymphatic\u2013immune axis in glioblastoma: mechanistic insights and translational opportunities","volume":"27","author":"Fiallo Arroyo","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.175681","article-title":"Fecal microbiome transplantation alleviates manganese-induced neurotoxicity by altering the composition and function of the gut microbiota via the cGAS\u2013STING\/NLRP3 pathway","volume":"951","author":"Liu","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.intimp.2026.116628_bb0185","article-title":"Advances in the role of cGAS-STING pathway on the repair of central nervous system injury based on gut microbiota","volume":"168","author":"Tao","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb0190","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101199R","article-title":"CGAS\u2013STING signaling pathway in gastrointestinal inflammatory disease and cancers","volume":"36","author":"Ke","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2026.116628_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-024-00643-z","article-title":"Phosphorylation of AQP4 by LRRK2 R1441G impairs glymphatic clearance of IFN\u03b3 and aggravates dopaminergic neurodegeneration","volume":"10","author":"Huang","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tins.2020.10.008","article-title":"Signaling by cGAS-STING in neurodegeneration, neuroinflammation and aging","volume":"44","author":"Paul","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0205","doi-asserted-by":"crossref","first-page":"1659216","DOI":"10.3389\/fnagi.2025.1659216","article-title":"STING-mediated neuroinflammation: a therapeutic target in neurodegenerative diseases","volume":"17","author":"Zhang","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10753-025-02388-0","article-title":"Astrocytic SIRT3 alleviates neuroinflammatory responses after cerebral ischemia\/reperfusion by inhibiting the cGAS-STING pathway","volume":"49","author":"Lei","year":"2026","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.intimp.2026.116628_bb0215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11011-023-01327-y","article-title":"The role of astrocytes in the glymphatic network: a narrative review","volume":"39","author":"Das","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fnana.2018.00113","article-title":"Advances in parkinsons disease: 200 years later","volume":"12","author":"Del Rey","year":"2018","journal-title":"Front. Neuroanat."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0225","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","article-title":"A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease","volume":"8","author":"Borghammer","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0230","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and parkinson disease","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2026.116628_bb0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.NT.0000520851.27938.0b","article-title":"Truncal vagotomy may protect against Parkinsons disease, study suggests","volume":"17","author":"Owens","year":"2017","journal-title":"Neurol. Today"},{"key":"10.1016\/j.intimp.2026.116628_bb0240","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of parkinsons disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172192","article-title":"Gut mucosal cells transfer \u03b1-synuclein to the vagus nerve","volume":"8","author":"Chandra","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2026.116628_bb0250","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models parkinsons disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.116628_bb0255","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/mds.29432","article-title":"The endotoxin hypothesis of parkinsons disease","volume":"38","author":"Brown","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0260","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-023-02846-2","article-title":"Lipopolysaccharide-binding protein and future parkinsons disease risk: a european prospective cohort","volume":"20","author":"Zhao","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116628_bb0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","volume":"11","author":"Parker","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.intimp.2026.116628_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212164","article-title":"Gut microbiota and immune system dynamics in parkinsons and alzheimers diseases","volume":"25","author":"Kustrimovic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40035-025-00531-3","article-title":"Microglia in the crosstalk between peripheral and central nervous systems in parkinsons disease","volume":"14","author":"Li","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116628_bb0280","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.3390\/ijms22158338","article-title":"The prion-like spreading of alpha-Synuclein in parkinsons disease: update on models and hypotheses","volume":"22","author":"Jan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.arr.2019.01.012","article-title":"The prion-like spreading of \u03b1-synuclein: from in vitro to in vivo models of parkinsons disease","volume":"50","author":"Vargas","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.intimp.2026.116628_bb0290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and \u03b1-Synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of parkinsons disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.intimp.2026.116628_bb0295","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/glia.24149","article-title":"Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding\/spreading mouse model of parkinsons disease","volume":"70","author":"Garcia","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116628_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinsons disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0305","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/antiox11010170","article-title":"Neuroprotection and disease modification by astrocytes and microglia in parkinson disease","volume":"11","author":"Takahashi","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.intimp.2026.116628_bb0310","first-page":"3599","article-title":"Astrocytes and microglia in the coordination of CNS development and homeostasis","volume":"168","author":"Lopez-Ortiz","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.116628_bb0315","article-title":"Ion channel dysfunction in astrocytes in neurodegenerative diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2026.116628_bb0320","article-title":"Astrocytes-associated research in Parkinsons disease: an explored trends analysis","volume":"17","author":"Chen","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0325","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","article-title":"Astrocyte-neuron metabolic cooperation shapes brain activity","volume":"33","author":"Bonvento","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.116628_bb0330","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116628_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162717","article-title":"Alpha-Synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant","volume":"11","author":"Hoenen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116628_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/biom16010156","article-title":"Microglia, astrocytes, and oligodendrocytes in Parkinson\u2019s disease: neuroinflammatory crosstalk and emerging therapeutic strategies","volume":"16","author":"K\u0119dzia","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116628_bb0345","first-page":"1","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116628_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0355","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in parkinsons disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116628_bb0360","doi-asserted-by":"crossref","first-page":"16025","DOI":"10.1038\/npjparkd.2016.25","article-title":"Parkinson\u2019s disease as a system-level disorder","volume":"2","author":"Caligiore","year":"2016","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00415-025-13545-8","article-title":"The role of the gut microbiome in the progression of parkinsons disease: a systematic review of patient cohorts","volume":"273","author":"Peters","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0370","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00415-025-13138-5","article-title":"The gut\u2013brain axis in early parkinsons disease: from prodrome to prevention","volume":"272","author":"Oliver","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.782082","article-title":"The gut\u2013brain axis and its relation to Parkinson\u2019s disease: a review","volume":"13","author":"Klann","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0380","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-021-00439-2","article-title":"Parkinson mice show functional and molecular changes in the gut long before motoric disease onset","volume":"16","author":"Gries","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"3:1","key":"10.1016\/j.intimp.2026.116628_bb0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0390","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","article-title":"The gut-brain axis: two ways signaling in parkinsons disease","volume":"42","author":"Dogra","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0395","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0400","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00797-20","article-title":"Short-chain fatty acid-producing gut microbiota is decreased in parkinsons disease but not in rapid-eye-movement sleep behavior disorder","volume":"5","author":"Nishiwaki","year":"2020","journal-title":"MSystems"},{"key":"10.1016\/j.intimp.2026.116628_bb0405","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/JPD-230315","article-title":"Do bacterial outer membrane vesicles contribute to chronic inflammation in parkinsons disease?","volume":"14","author":"Koukoulis","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0410","article-title":"Intranasal LPS-mediated parkinsons model challenges the pathogenesis of nasal cavity and environmental toxins","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116628_bb0415","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuint.2015.06.004","article-title":"Characterization of the lipopolysaccharide induced model of parkinsons disease: role of oxidative stress and neuroinflammation","volume":"87","author":"Sharma","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.intimp.2026.116628_bb0420","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41531-021-00263-x","article-title":"Enteric \u03b1-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in parkinsons disease before brain pathology","volume":"8","author":"Pellegrini","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1348279","article-title":"Dysbiosis of the gut microbiota and its effect on \u03b1-synuclein and prion protein misfolding: consequences for neurodegeneration","volume":"14","author":"Mahbub","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.116628_bb0430","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models parkinsons disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.116628_bb0435","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and parkinson disease","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2026.116628_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70003","article-title":"Fecal microbiota from patients with parkinsons disease intensifies inflammation and neurodegeneration in A53T mice","volume":"30","author":"Yang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2026.116628_bb0445","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.14336\/AD.2023.0309","article-title":"Healthy human fecal microbiota transplantation into mice attenuates MPTP-induced neurotoxicity via AMPK\/SOD2 pathway","volume":"14","author":"Xie","year":"2023","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0450","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1038\/s41467-025-56829-3","article-title":"Machine learning-based meta-analysis reveals gut microbiome alterations associated with Parkinson\u2019s disease","volume":"16","author":"Romano","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116628_bb0455","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","article-title":"Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens","volume":"6","author":"Wallen","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of parkinsons disease is associated with gut dysbiosis: two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116628_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.615075","article-title":"Review: the role of intestinal dysbiosis in parkinsons disease","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.116628_bb0470","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2020.02.030","article-title":"The link between gut dysbiosis and neuroinflammation in parkinsons disease","volume":"432","author":"Baizabal-Carvallo","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2026.116628_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121356","article-title":"The effects of gallic acid and vagotomy on motor function, intestinal transit, brain electrophysiology and oxidative stress alterations in a rat model of parkinsons disease induced by rotenone","volume":"315","author":"Sheikhpour","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0480","doi-asserted-by":"crossref","first-page":"1546203","DOI":"10.3389\/fnins.2025.1546203","article-title":"Exploring the relationship between GBA1 host genotype and gut microbiome in the GBA1L444P\/WT mouse model: implications for parkinsons disease pathogenesis","volume":"19","author":"Menozzi","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0485","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X20957225","article-title":"Dysfunction of the microbiota-gut-brain axis in neurodegenerative disease: the promise of therapeutic modulation with prebiotics, medicinal herbs, probiotics, and synbiotics","volume":"25","author":"Peterson","year":"2020","journal-title":"j. evid. Based. Integr. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0490","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41531-025-00950-z","article-title":"Proinflammatory and GABA eating bacteria in Parkinson\u2019s disease gut microbiome from a meta-analysis perspective","volume":"11","author":"Marzouk","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0495","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","article-title":"A postmortem study suggests a revision of the dual-hit hypothesis of parkinsons disease","volume":"8","author":"Borghammer","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0500","doi-asserted-by":"crossref","unstructured":"T.R. Sampson, Z.D. Wallen, W.J. Won, D.G. Standaert, H. Payami, A.S. Harms, Alpha synuclein overexpression can drive microbiome dysbiosis in mice, Sci. Rep. 2025 15:1 4014. doi:https:\/\/doi.org\/10.1038\/s41598-024-82139-7.","DOI":"10.1038\/s41598-024-82139-7"},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0505","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41380-025-03281-w","article-title":"Early-life microbiota dysbiosis as a link between Autism Spectrum Disorder and Parkinson\u2019s Disease","volume":"31","author":"Zhao","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.intimp.2026.116628_bb0510","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3390\/ijms22137030","article-title":"Evidence for the role of mitochondrial DNA release in the inflammatory response in neurological disorders","volume":"22","author":"Moya","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0515","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-025-02302-8","article-title":"TFAM deficiency triggers mtDNA leakage and cGAS-STING-mediated intestinal ischemia-reperfusion injury","author":"Ding","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2026.116628_bb0520","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116628_bb0525","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-\u03baB that mediate immune defense against tumors and viral infections","volume":"118","author":"Yum","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116628_bb0530","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202310150","article-title":"A STING\u2013CASM\u2013GABARAP pathway activates LRRK2 at lysosomes","volume":"224","author":"Bentley-Desousa","year":"2025","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116628_bb0535","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202310150","article-title":"A STING-CASM-GABARAP pathway activates LRRK2 at lysosomes","volume":"224","author":"Bentley-Desousa","year":"2025","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116628_bb0540","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","article-title":"The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of parkinsons disease via LCN2-dependent astrocyte senescence","volume":"30","author":"Jiang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.116628_bb0545","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1111\/cns.14157","article-title":"Microglial cGAS drives neuroinflammation in the MPTP mouse models of parkinsons disease","volume":"29","author":"Ma","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2026.116628_bb0550","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/1570159X19666210924110144","article-title":"CGAS-STING-mediated IFNI response in host defense and neuroinflammatory diseases","volume":"20","author":"Chen","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb0555","article-title":"The contribution of type-I IFN-mediated neuroinflammation to parkinsons disease progression","volume":"46","author":"Chen","year":"2025","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.intimp.2026.116628_bb0560","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.parkreldis.2011.07.003","article-title":"CGMP level in idiopathic parkinsons disease patients with and without cardiovascular disease - a pilot study","volume":"17","author":"Brodacki","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0565","article-title":"The STING inhibitor c-176 attenuates MPTP-induced neuroinflammation and neurodegeneration in mouse parkinsonian models","volume":"124","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10571-025-01550-4","article-title":"The STING signaling: a novel target for central nervous system diseases","volume":"45","author":"Song","year":"2025","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.116628_bb0575","article-title":"The contribution of type-I IFN-mediated neuroinflammation to parkinsons disease progression","volume":"46","author":"Chen","year":"2025","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.intimp.2026.116628_bb0580","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/jcm9103323","article-title":"Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy","volume":"9","author":"Aval","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70146","article-title":"CGAS\u2013STING signaling in central nervous system diseases: Neuroinflammatory mechanisms and immune regulation","volume":"43","author":"Wang","year":"2025","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.intimp.2026.116628_bb0590","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14671","article-title":"The cytosolic DNA-sensing cGAS\u2013STING pathway in neurodegenerative diseases","volume":"30","author":"Guo","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2026.116628_bb0595","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13024-023-00666-9","article-title":"CGAS-STING triggers inflammaging-associated neurodegeneration","volume":"18","author":"Izquierdo","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116628_bb0600","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3390\/antiox14111276","article-title":"CGAS\u2013STING\u2013NF-\u03baB axis mediates rotenone-induced NLRP3 inflammasome activation through mitochondrial DNA release","volume":"14","author":"Mun","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.intimp.2026.116628_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.845930","article-title":"Neuroinflammation upregulated neuronal toll-like receptors 2 and 4 to drive synucleinopathy in neurodegeneration","volume":"13","author":"Chung","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114692","article-title":"Alpha-Synuclein drives NURR1 and NLRP3 inflammasome dysregulation in parkinsons disease: from pathogenesis to potential therapeutic strategies","volume":"156","author":"Abdelaziz","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb0615","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.2100035","article-title":"Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct \u03b1-Synuclein assemblies","volume":"207","author":"Scheiblich","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.116628_bb0620","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4103\/NRR.NRR-D-23-01684","article-title":"The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in parkinsons disease","volume":"20","author":"Zhou","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb0625","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5607\/en.2019.28.5.547","article-title":"Targeting microglial and neuronal toll-like receptor 2 in synucleinopathies","volume":"28","author":"Kwon","year":"2019","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.intimp.2026.116628_bb0630","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00336-21","article-title":"Molecular mechanisms of the toll-like receptor, STING, MAVS, inflammasome, and interferon pathways","volume":"6","author":"Manes","year":"2021","journal-title":"MSystems"},{"key":"10.1016\/j.intimp.2026.116628_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109986","article-title":"Cilostazol novel neuroprotective mechanism against rotenone-induced parkinsons disease in rats: correlation between nrf2 and HMGB1\/TLR4\/PI3K\/Akt\/mTOR signaling","volume":"117","author":"El-Sayed","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054628","article-title":"LPS triggers acute neuroinflammation and parkinsonism involving NLRP3 inflammasome pathway and mitochondrial CI dysfunction in the rat","volume":"24","author":"Valenzuela-Arzeta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0645","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"issue":"1 4","key":"10.1016\/j.intimp.2026.116628_bb0650","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116628_bb0655","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imr.13131","article-title":"Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases","volume":"313","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.116628_bb0660","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.intimp.2026.116628_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105313","article-title":"Complement system changes in blood in parkinsons disease and progressive supranuclear palsy\/Corticobasal syndrome","volume":"108","author":"Khosousi","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0670","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41419-021-04049-0","article-title":"Fibrillar \u03b1-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-\u03baB","volume":"12","author":"Chou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0675","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1354-7","article-title":"STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury","volume":"15","author":"Abdullah","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116628_bb0680","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12272-023-01452-3","article-title":"Beyond DNA sensing: expanding the role of cGAS\/STING in immunity and diseases","volume":"46","author":"Seok","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb0685","doi-asserted-by":"crossref","first-page":"1528995","DOI":"10.3389\/fncel.2025.1528995","article-title":"Glymphatic system: a self-purification circulation in brain","volume":"19","author":"Chen","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106710","article-title":"The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellular and molecular mechanisms in neurodegenerative diseases","volume":"202","author":"Zhang","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0695","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42466-021-00102-7","article-title":"Glymphatic system, AQP4, and their implications in alzheimers disease","volume":"3","author":"Silva","year":"2021","journal-title":"Neurol. Res. Pract."},{"issue":"1 11","key":"10.1016\/j.intimp.2026.116628_bb0700","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41531-025-01139-0","article-title":"The effects of aquaporin-4 polymorphisms on glymphatic function and motor symptoms in Parkinson\u2019s disease","volume":"11","author":"Qin","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"issue":"6 27","key":"10.1016\/j.intimp.2026.116628_bb0705","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41593-024-01638-y","article-title":"Brain clearance is reduced during sleep and anesthesia","volume":"27","author":"Miao","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0710","article-title":"The left DTI-ALPS index: a potential glymphatic mediator of cognitive and motor dysfunction in parkinsons disease","volume":"12","author":"Li","year":"2025","journal-title":"Front. Med. (Lausanne)."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0715","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41531-025-01151-4","article-title":"A systematic review and meta-analysis on glymphatic flow dysfunction in Parkinson\u2019s disease and Parkinsonism spectrum","volume":"11","author":"Ghaderi","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0720","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13195-025-01842-3","article-title":"Evaluation and interpretation of DTI-ALPS, a proposed surrogate marker for glymphatic clearance, in a large population-based sample","volume":"17","author":"Satpathi","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.intimp.2026.116628_bb0725","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17816\/ACEN.1127","article-title":"Glymphatic system assessment using DTI-ALPS in age-dependent neurodegenerative diseases","volume":"18","author":"Liaskovik","year":"2024","journal-title":"Ann. Clin. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0730","doi-asserted-by":"crossref","first-page":"26381","DOI":"10.1038\/s41598-024-78132-9","article-title":"Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"14","author":"Costa","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116628_bb0735","article-title":"Aquaporin-4 mis-localization slows glymphatic clearance of \u03b1-synuclein and promotes \u03b1-synuclein pathology and aggregate propagation","author":"Braun","year":"2024","journal-title":"BioRxiv"},{"key":"10.1016\/j.intimp.2026.116628_bb0740","article-title":"Postmortem analysis reveals distinct patterns of aquaporin-4 in parkinson disease and multiple system atrophy | NeurologyLive","year":"2026","journal-title":"Clinical Neurology News and Neurology Expert Insights"},{"key":"10.1016\/j.intimp.2026.116628_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-025-01139-0","article-title":"The effects of aquaporin-4 polymorphisms on glymphatic function and motor symptoms in parkinsons disease","volume":"11","author":"Qin","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0750","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-022-00999-5","article-title":"Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid \u03b2 plaque formation in mice","volume":"14","author":"Simon","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.intimp.2026.116628_bb0755","series-title":"Relationship between \u03b1-synuclein aggregate accumulation and aquaporin-4 expression in multiple system atrophy and Dementia with Lewy Bodies","author":"Magnier","year":"2024"},{"key":"10.1016\/j.intimp.2026.116628_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2026.121760","article-title":"Associations between glymphatic dysfunction, white matter injury, and cognitive decline in parkinsons disease","volume":"327","author":"Yao","year":"2026","journal-title":"Neuroimage"},{"key":"10.1016\/j.intimp.2026.116628_bb0765","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neubiorev.2018.03.028","article-title":"Interaction between blood-brain barrier and glymphatic system in solute clearance","volume":"90","author":"Verheggen","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2026.116628_bb0770","doi-asserted-by":"crossref","DOI":"10.20517\/and.2023.56","article-title":"Sleep, glymphatic system, and Parkinson\u2019s disease","volume":"4","author":"Wang","year":"2024","journal-title":"Ageing Neur Dis"},{"key":"10.1016\/j.intimp.2026.116628_bb0775","article-title":"Glymphatic dysfunction: a bridge between sleep disturbance and mood disorders","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.intimp.2026.116628_bb0780","article-title":"Associations among cognitive functions, plasma DNA, and diffusion tensor image along the perivascular space (DTI-ALPS) in patients with parkinsons disease","volume":"2021","author":"Chen","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2026.116628_bb0785","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.29908","article-title":"Diffusion tensor imaging-along the perivascular-space index is associated with disease progression in parkinsons disease","volume":"39","author":"Wood","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.108014","article-title":"Changes in DTI-ALPS index and its associations with neuronal damage in lewy body disease","volume":"140","author":"Firbank","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0795","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/mds.30325","article-title":"Impaired glymphatic clearance, measured using diffusion tensor image analysis along the perivascular space (DTI-ALPS), is linked to poor cognitive outcomes in parkinsons disease","volume":"40","author":"Zarkali","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb0800","doi-asserted-by":"crossref","first-page":"14108","DOI":"10.1073\/pnas.241508198","article-title":"Syntrophin-dependent expression and localization of aquaporin-4 water channel protein","volume":"98","author":"Neely","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116628_bb0805","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40478-022-01498-2","article-title":"Sleep fragmentation affects glymphatic system through the different expression of AQP4 in wild type and 5xFAD mouse models","volume":"11","author":"Vasciaveo","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2026.116628_bb0810","article-title":"Glymphatic dysfunction: a bridge between sleep disturbance and mood disorders","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.intimp.2026.116628_bb0815","article-title":"cGAS-STING-mediated inflammation and neurodegeneration as a strategy for the treatment of neurodegenerative diseases: role of mtDNA-cGAS-STING in neurodegenerative diseases","volume":"56","author":"Luo","year":"2023","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.intimp.2026.116628_bb0820","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12031-021-01836-4","article-title":"Decreased AQP4 expression aggravates \u03b1-Synuclein pathology in parkinsons disease mice, possibly via impaired glymphatic clearance","volume":"71","author":"Cui","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0825","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf029","article-title":"Glymphatic dysfunction exacerbates cognitive decline by triggering cortical degeneration in parkinsons disease: evidence from diffusion-tensor MRI","volume":"7","author":"Zhao","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.intimp.2026.116628_bb0830","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/0271678X221098145","article-title":"The meningeal lymphatic vessels and the glymphatic system: potential therapeutic targets in neurological disorders","volume":"42","author":"Li","year":"2022","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2026.116628_bb0835","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13578-022-00942-z","article-title":"Overview of the meningeal lymphatic vessels in aging and central nervous system disorders","volume":"12","author":"Jiang","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0840","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80775","article-title":"Meningeal lymphatic drainage promotes t cell responses against toxoplasma gondii but is dispensable for parasite control in the brain","volume":"11","author":"Kovacs","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2026.116628_bb0845","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41419-024-06863-8","article-title":"MtDNA release promotes cGAS-STING activation and accelerated aging of postmitotic muscle cells","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb0850","article-title":"cGAS-STING-mediated inflammation and neurodegeneration as a strategy for the treatment of neurodegenerative diseases: role of mtDNA-cGAS-STING in neurodegenerative diseases","volume":"56","author":"Luo","year":"2023","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.intimp.2026.116628_bb0855","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s42003-024-05911-5","article-title":"Glymphatic and lymphatic communication with systemic responses during physiological and pathological conditions in the central nervous system","volume":"7","author":"Licastro","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.intimp.2026.116628_bb0860","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb0865","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.3390\/ijms22147491","article-title":"The glymphatic system (en)during inflammation","volume":"22","author":"Mogensen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb0870","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.639140","article-title":"Glymphatic system as a gateway to connect neurodegeneration from periphery to CNS","volume":"15","author":"Natale","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0875","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/0271678X221098145","article-title":"The meningeal lymphatic vessels and the glymphatic system: potential therapeutic targets in neurological disorders","volume":"42","author":"Li","year":"2022","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2026.116628_bb0880","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2025.03.006","article-title":"Glymphatics and meningeal lymphatics unlock the brain-immune code","volume":"58","author":"Kim","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116628_bb0885","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1172\/JCI90603","article-title":"Understanding the functions and relationships of the glymphatic system and meningeal lymphatics","volume":"127","author":"Louveau","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.116628_bb0890","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1528995","article-title":"Glymphatic system: a self-purification circulation in brain","volume":"19","author":"Chen","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0895","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s11481-013-9470-8","article-title":"Drainage of cells and soluble antigen from the CNS to regional lymph nodes","volume":"8","author":"Laman","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0900","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1186\/s40001-025-03048-7","article-title":"Impairment of the intracranial lymphatic system in Parkinson\u2019s disease: a combined study of the meningeal lymphatics vessels and glymphatic system based on noninvasive neuroimaging","volume":"30","author":"Huang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb0905","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.neuron.2025.10.036","article-title":"Resolving the mysteries of brain clearance and immune surveillance","volume":"113","author":"Kipnis","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.116628_bb0910","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00613","article-title":"T cell trafficking through lymphatic vessels","volume":"7","author":"Hunter","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116628_bb0915","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/ejn.14290","article-title":"Immune system responses in parkinsons disease: early and dynamic","volume":"49","author":"Tansey","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0920","doi-asserted-by":"crossref","unstructured":"J.F. Osuna-Ramos, J. Camberos-Barraza, L.E. Torres-Mondrag\u00f3n, \u00c1.R. R\u00e1bago-Monz\u00f3n, A. Camacho-Zamora, M.A. Valdez-Flores, C.E. Angulo-Rojo, A.M. Guadr\u00f3n-Llanos, V.J. Picos-C\u00e1rdenas, L. Calder\u00f3n-Zamora, J.A. Maga\u00f1a-G\u00f3mez, C.D. Norzagaray-Valenzuela, F.I. C\u00e1rdenas-Torres, A.K. De la Herr\u00e1n-Arita, Interplay between the Glymphatic System and the Endocannabinoid System: implications for brain health and disease, Int. J. Mol. Sci. 2023, Vol. 24, Page 17458 24 (2023) 17458. doi:https:\/\/doi.org\/10.3390\/ijms242417458.","DOI":"10.3390\/ijms242417458"},{"key":"10.1016\/j.intimp.2026.116628_bb0925","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1138769","article-title":"Glymphatic system: an emerging therapeutic approach for neurological disorders","volume":"16","author":"Gao","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0930","series-title":"The gut\u2013brain\u2013immune triad in neurodegeneration: an integrated perspective","first-page":"136","volume":"3","author":"Chakrabarti","year":"2025"},{"key":"10.1016\/j.intimp.2026.116628_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116698","article-title":"Relationship between the cGAS\u2212STING and NF-\u03baB pathways-role in neurotoxicity","volume":"175","author":"Zhong","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116628_bb0940","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2022.04.006","article-title":"The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis","volume":"55","author":"Erttmann","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116628_bb0945","doi-asserted-by":"crossref","unstructured":"S. Quan, X. Fu, H. Cai, Z. Ren, Y. Xu, L. Jia, The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer's disease, Mol. Neurodegener. 2025 20:1 20 (2025) 25-. doi:https:\/\/doi.org\/10.1186\/s13024-025-00815-2.","DOI":"10.1186\/s13024-025-00815-2"},{"issue":"7","key":"10.1016\/j.intimp.2026.116628_bb0950","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0955","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.immuni.2021.05.008","article-title":"Dysbiosis exacerbates colitis by promoting ubiquitination and accumulation of the innate immune adaptor STING in myeloid cells","volume":"54","author":"Shmuel-Galia","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116628_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.759679","article-title":"Neuro-immunity and gut dysbiosis drive parkinsons disease-induced pain","volume":"12","author":"Roversi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116628_bb0965","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in parkinsons disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb0970","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.intimp.2026.116628_bb0975","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41598-025-29692-x","article-title":"Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in parkinsons disease: a randomized double-blind prospective study","volume":"16","author":"Hegelmaier","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116628_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1600148","article-title":"Gut dysbiosis as a potential driver of parkinsons and alzheimers disease pathogenesis","volume":"19","author":"Pfaffinger","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb0985","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/molecules31030490","article-title":"Gut dysbiosis and microbiota-derived metabolites in neurodegenerative diseases: molecular and biochemical mechanisms along the gut\u2013brain axis","volume":"31","author":"Czaj","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116628_bb0990","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced parkinsons disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.intimp.2026.116628_bb0995","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam5613","article-title":"Triggering neurodegeneration from the gut","volume":"9","author":"Wong","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2026.116628_bb1000","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12017-019-08539-5","article-title":"Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in \u03b1-Synuclein mutant mice","volume":"21","author":"Kishimoto","year":"2019","journal-title":"NeuroMolecular Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.116628_bb1005","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1007\/s12035-018-0937-8","article-title":"Bidirectional neural interaction between central dopaminergic and gut lesions in Parkinson\u2019s disease models","volume":"55","author":"Garrido-Gil","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.116628_bb1010","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.3390\/ijms21238899","article-title":"A budding relationship: bacterial extracellular vesicles in the microbiota-gut-brain axis","volume":"21","author":"Haas-neill","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1015","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.3390\/ijms22084235","article-title":"Role of microbiota-derived extracellular vesicles in gut-brain communication","volume":"22","author":"Cuesta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1020","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.93","article-title":"The use of a multicellular in vitro model to investigate uptake and migration of bacterial extracellular vesicles derived from the human gut commensal bacteroides thetaiotaomicron","volume":"2","author":"Modasia","year":"2023","journal-title":"Journal of Extracellular Biology"},{"key":"10.1016\/j.intimp.2026.116628_bb1025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13041-025-01263-1","article-title":"Molecular mechanisms of gut microbiota dysbiosis and metabolites in alzheimers disease pathogenesis: implications for precision therapeutics","volume":"18","author":"Vaziri","year":"2025","journal-title":"Mol. Brain"},{"key":"10.1016\/j.intimp.2026.116628_bb1030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204058119","article-title":"Alpha-synuclein-mediated DNA damage, STING activation, and neuroinflammation in parkinsons disease","volume":"119","author":"Standaert","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116628_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157493","article-title":"Protocatechuic acid alleviates cGAS-STING-mediated neuroinflammation by enhancing microglial autophagy in mouse models of parkinsons disease","volume":"148","author":"Rui","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2026.116628_bb1040","doi-asserted-by":"crossref","DOI":"10.3390\/biom15101398","article-title":"Microbiota-derived extracellular vesicles as potential mediators of gut\u2013brain communication in traumatic brain injury: mechanisms, biomarkers, and therapeutic implications","volume":"15","author":"Benameur","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116628_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106426","article-title":"The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: a vicious cycle","volume":"192","author":"Cai","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb1050","doi-asserted-by":"crossref","DOI":"10.1063\/5.0261875","article-title":"Astrocyte-driven vasoconstriction impairs glymphatic clearance in a human tauopathy-on-chip model","volume":"9","author":"Park","year":"2025","journal-title":"APL Bioeng."},{"key":"10.1016\/j.intimp.2026.116628_bb1055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/iub.2903","article-title":"Microglia synchronizes with the circadian rhythm of the glymphatic system and modulates glymphatic system function","volume":"76","author":"Yang","year":"2024","journal-title":"IUBMB Life"},{"key":"10.1016\/j.intimp.2026.116628_bb1060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000490349","article-title":"The glymphatic system and waste clearance with brain aging: a review","volume":"65","author":"Benveniste","year":"2019","journal-title":"Gerontology"},{"key":"10.1016\/j.intimp.2026.116628_bb1065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41531-024-00844-6","article-title":"Comparison of vagus nerve cross-sectional area between brain-first and body-first parkinsons disease","volume":"10","author":"Dong","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb1070","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3390\/biomedicines10092261","article-title":"The role of glymphatic system in alzheimers and parkinsons disease pathogenesis","volume":"10","author":"Buccellato","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116628_bb1075","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4103\/1673-5374.391312","article-title":"Glymphatic system: a gateway for neuroinflammation","volume":"19","author":"Zou","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1080","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/MS9.0000000000004598","article-title":"Neuroinflammation-driven glymphatic dysfunction: implications for disease progression and drug-based modulation","volume":"88","author":"Batool","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.intimp.2026.116628_bb1085","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4103\/1673-5374.391312","article-title":"Glymphatic system: a gateway for neuroinflammation","volume":"19","author":"Zou","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1090","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4103\/NRR.NRR-D-24-00442","article-title":"Brain endothelial cyclic GMP-AMP synthase (cGAS)\u2013stimulator of interferon genes (STING) signaling pathway in aging and neurodegeneration","volume":"20","author":"Sun","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1095","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","article-title":"Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of alzheimers disease pathologies","volume":"56","author":"Chung","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1100","doi-asserted-by":"crossref","DOI":"10.31083\/JIN39286","article-title":"Inhibition of cGAS reduces brain injury and facilitates neurological recovery via the STING-mediated signaling pathway after germinal matrix hemorrhage in neonatal mice","volume":"24","author":"Wang","year":"2025","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb1105","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/nar\/gkad1184","article-title":"CGAS-STING signalling regulates microglial chemotaxis in genome instability","volume":"52","author":"Talbot","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2017.08.039","article-title":"Human microglia and astrocytes express cGAS-STING viral sensing components","volume":"658","author":"Jeffries","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2026.116628_bb1115","article-title":"Microglia-astrocyte interaction underlies aquaporin-4 dysregulation in the mouse cortex","author":"Wang","year":"2025","journal-title":"BioRxiv"},{"key":"10.1016\/j.intimp.2026.116628_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbii.2025.100143","article-title":"New mechanisms of aging: from vascular to neurological system","volume":"12","author":"Hu","year":"2025","journal-title":"Brain Behavior and Immunity Integrative"},{"key":"10.1016\/j.intimp.2026.116628_bb1125","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1073\/pnas.0437946100","article-title":"An \u03b1-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain","volume":"100","author":"Amiry-Moghaddam","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116628_bb1130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/glia.24494","article-title":"Proteomic profiling of interferon-responsive reactive astrocytes in rodent and human","volume":"72","author":"Prakash","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116628_bb1135","article-title":"Type i interferon response is mediated by NLRX1-cGAS-STING signaling in brain injury","volume":"15","author":"Fritsch","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb1140","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/ijms25031672","article-title":"Aquaporin-4 and parkinsons disease","volume":"25","author":"Lapshina","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1145","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/mds.70023","article-title":"Distinct AQP4 alterations in movement disorders with primary synucleinopathy","volume":"40","author":"Wang","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116628_bb1150","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","article-title":"The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of parkinsons disease via LCN2-dependent astrocyte senescence","volume":"30","author":"Jiang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.116628_bb1155","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82232","article-title":"Loss of aquaporin-4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation","volume":"12","author":"Gomolka","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2026.116628_bb1160","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.62347\/ANQP2661","article-title":"DTI-ALPS index as a predictor of glymphatic system dysfunction in cerebral infarction","volume":"17","author":"Lin","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1165","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101350","article-title":"Tissue inflammation induced by constitutively active STING is mediated by enhanced TNF signaling","volume":"14","author":"Luksch","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2026.116628_bb1170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbi.2025.06.042","article-title":"Microglial cGAS-STING-TBK1 activation in paraventricular thalamus mediates sleep and emotional disturbances in lupus mice","volume":"129","author":"Yuan","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.116628_bb1175","article-title":"Glymphatic clearance is enhanced during sleep","author":"Kroesbergen","year":"2024","journal-title":"BioRxiv"},{"key":"10.1016\/j.intimp.2026.116628_bb1180","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/brainsci10110868","article-title":"The sleeping brain: harnessing the power of the glymphatic system through lifestyle choices","volume":"10","author":"Reddy","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1185","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-025-02959-w","article-title":"When sleep fails, brain clearance suffers: the role of glymphatic impairment in clinical neurology","author":"De la Herr\u00e1n-Arita","year":"2025","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.intimp.2026.116628_bb1190","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41593-024-01638-y","article-title":"Brain clearance is reduced during sleep and anesthesia","volume":"27","author":"Miao","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb1195","doi-asserted-by":"crossref","DOI":"10.53053\/JXNY1456","article-title":"New method reignites controversy over brain clearance during sleep","author":"Welle","year":"2024","journal-title":"The Transmitter"},{"key":"10.1016\/j.intimp.2026.116628_bb1200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116628_bb1205","article-title":"Aberrant waste disposal in neurodegeneration: why improved sleep could be the solution","volume":"2","author":"Wafford","year":"2021","journal-title":"Cereb. Circ. Cogn. Behav."},{"key":"10.1016\/j.intimp.2026.116628_bb1210","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X251333933","article-title":"Cerebral small vessel disease: the impact of glymphopathy and sleep disorders","volume":"45","author":"Hein","year":"2025","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2026.116628_bb1215","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3390\/biomedicines13082025","article-title":"Systemic neurodegeneration and brain aging: multi-omics disintegration, proteostatic collapse, and network failure across the CNS","volume":"13","author":"Voicu","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116628_bb1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00368","article-title":"Oxidized mitochondrial DNA activates the cGAS-STING pathway in the neuronal intrinsic immune system after brain ischemia-reperfusion injury","volume":"21","author":"Li","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.intimp.2026.116628_bb1225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.04.009","article-title":"Mitochondrial DNA leakage and cGas\/STING pathway in microglia: crosstalk between neuroinflammation and neurodegeneration","volume":"548","author":"Liu","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2026.116628_bb1230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/biom15010033","article-title":"VDAC1: a key player in the mitochondrial landscape of neurodegeneration","volume":"15","author":"Argueti-Ostrovsky","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116628_bb1235","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","article-title":"Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production","volume":"74","author":"Tapias","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1240","doi-asserted-by":"crossref","first-page":"18467","DOI":"10.1074\/jbc.M115.641746","article-title":"\u0391-Synuclein shows high affinity interaction with voltage-dependent anion channel, suggesting mechanisms of mitochondrial regulation and toxicity in parkinson disease","volume":"290","author":"Rostovtseva","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116628_bb1245","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.3390\/ijms24044020","article-title":"Cytosolic release of mitochondrial DNA and associated cGAS signaling mediates radiation-induced hematopoietic injury of mice","volume":"24","author":"Guan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2025.09.018","article-title":"VDAC1 oligomerization-mediated mtDNA release under sublethal oxidative stress: a novel inflammatory mechanism in vitiligo","volume":"241","author":"Gao","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1255","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.2147\/JIR.S468609","article-title":"Novel insights into Parkin\u2013mediated mitochondrial dysfunction and \u201cmito-inflammation\u201d in \u03b1-synuclein toxicity. The role of the cGAS\u2013STING signalling pathway","volume":"17","author":"G\u0105ssowska-Dobrowolska","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1260","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/biom11050718","article-title":"Alpha-Synuclein and mitochondrial dysfunction in parkinsons disease: the emerging role of VDAC","volume":"11","author":"Risiglione","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116628_bb1265","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.2147\/JIR.S468609","article-title":"Novel insights into Parkin\u2013mediated mitochondrial dysfunction and \u201cmito-inflammation\u201d in \u03b1-synuclein toxicity. The role of the cGAS\u2013STING signalling pathway","volume":"17","author":"G\u0105ssowska-Dobrowolska","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1270","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","article-title":"Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production","volume":"74","author":"Tapias","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1275","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-023-06251-8","article-title":"Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization","volume":"14","author":"Lurette","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb1280","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.3390\/ijms241210366","article-title":"Glymphatic system and mitochondrial dysfunction as two crucial players in pathophysiology of neurodegenerative disorders","volume":"24","author":"Kope\u0107","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1193","article-title":"Intracellular delivery of parkin rescues neurons from accumulation of damaged mitochondria and pathological \u03b1-synuclein","volume":"6","author":"Chung","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2026.116628_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106791","article-title":"New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases","volume":"205","author":"Sun","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb1295","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13082025","article-title":"Systemic neurodegeneration and brain aging: multi-omics disintegration, proteostatic collapse, and network failure across the CNS","volume":"13","author":"Voicu","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116628_bb1300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurol.2023.11.004","article-title":"The gut-brain axis in parkinsons disease","volume":"180","author":"Bonaz","year":"2024","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.intimp.2026.116628_bb1305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/1570159X18666200606233050","article-title":"Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated parkinsons disease","volume":"19","author":"Kaur","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.intimp.2026.116628_bb1310","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103092","article-title":"Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to parkinsons disease and therapeutic implications","volume":"71","author":"Kalyanaraman","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2026.116628_bb1315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2025.106065","article-title":"Crosstalk between DNA damage and cGAS-STING immune pathway drives neuroinflammation and dopaminergic neurodegeneration in parkinsons disease","volume":"130","author":"Khan","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.116628_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2026.150000","article-title":"CGAS-STING activation in parkinsons disease: from mechanisms to disease-modifying therapeutic strategies","volume":"985","author":"Solomon","year":"2026","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2026.116628_bb1325","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41531-024-00643-z","article-title":"Phosphorylation of AQP4 by LRRK2 R1441G impairs glymphatic clearance of IFN\u03b3 and aggravates dopaminergic neurodegeneration","volume":"10","author":"Huang","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb1330","article-title":"Glymphatic system dysfunction and sleep disturbance may contribute to the pathogenesis and progression of parkinsons disease","volume":"23","author":"Scott-Massey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1335","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41531-022-00316-9","article-title":"Neuroimaging evidence of glymphatic system dysfunction in possible REM sleep behavior disorder and parkinsons disease","volume":"8","author":"Si","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb1340","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s11033-025-11129-3","article-title":"Interplay between gut Microbiome and glymphatic system in cognitive function and memory regulation","volume":"52","author":"Alavian","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2026.116628_bb1345","first-page":"S281","article-title":"Brain-first versus gut-first parkinsons disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb1350","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.791213","article-title":"To the gut microbiome and beyond: the brain-first or body-first hypothesis in parkinsons disease","volume":"13","author":"Nuzum","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.116628_bb1355","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","article-title":"Constipation preceding parkinsons disease: a systematic review and meta-analysis","volume":"87","author":"Adams-Carr","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2026.116628_bb1360","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.871710","article-title":"Exploring the causal effect of constipation on parkinsons disease through mediation analysis of microbial data","volume":"12","author":"Fu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.116628_bb1365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/brainsci14010100","article-title":"Exploring Parkinson\u2019s Disease-Associated Depression: Role of Inflammation on the Noradrenergic and Serotonergic Pathways","volume":"14","author":"Sampaio","year":"2024","journal-title":"Brain Sciences"},{"key":"10.1016\/j.intimp.2026.116628_bb1370","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2147\/NDT.S480183","article-title":"Relationship of glymphatic function with cognitive impairment, sleep disorders, anxiety and depression in patients with parkinsons disease","volume":"20","author":"Gui","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb1375","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116628_bb1380","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/jgh.16974","article-title":"CGAS-STING pathways impact on intestinal barrier","volume":"40","author":"Li","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.116628_bb1385","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2026.116628_bb1390","doi-asserted-by":"crossref","first-page":"1610029","DOI":"10.3389\/fmicb.2025.1610029","article-title":"Microbiome engineering: unlocking therapeutic potential in inflammatory bowel disease","volume":"16","author":"Kong","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.116628_bb1395","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tibtech.2021.08.002","article-title":"Discovery and delivery strategies for engineered live biotherapeutic products","volume":"40","author":"Heavey","year":"2021","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb1400","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1038\/s41467-024-48770-8","article-title":"Binding of Akkermansia muciniphila to mucin is O-glycan specific","volume":"15","author":"Elzinga","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116628_bb1405","doi-asserted-by":"crossref","first-page":"6","DOI":"10.20517\/mrr.2023.05","article-title":"Mode of action of akkermansia muciniphila in the intestinal dialogue: role of extracellular proteins, metabolites and cell envelope components","volume":"2","author":"Segers","year":"2023","journal-title":"Microbiome Research Reports"},{"key":"10.1016\/j.intimp.2026.116628_bb1410","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13099-024-00635-7","article-title":"The influence of akkermansia muciniphila on intestinal barrier function","volume":"16","author":"Mo","year":"2024","journal-title":"Gut Pathog."},{"key":"10.1016\/j.intimp.2026.116628_bb1415","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymben.2023.09.008","article-title":"Metabolic engineering of commensal bacteria for gut butyrate delivery and dissection of host-microbe interaction","volume":"80","author":"Gong","year":"2023","journal-title":"Metab. Eng."},{"key":"10.1016\/j.intimp.2026.116628_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117689","article-title":"Butyrate modulates gut microbiota and anti-inflammatory response in attenuating cisplatin-induced kidney injury","volume":"181","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116628_bb1425","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s12967-025-06544-w","article-title":"Inhibition of histone deacetylases 3 attenuates imiquimod-induced psoriatic dermatitis via targeting cGAS-STING signaling in keratinocytes","volume":"23","author":"Zeng","year":"2025","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.116628_bb1430","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s44319-024-00358-5","article-title":"HDAC6 deacetylates TRIM56 to negatively regulate cGAS-STING-mediated type I interferon responses","volume":"26","author":"Zeng","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2026.116628_bb1435","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13102483","article-title":"Larazotide acetate protects the intestinal mucosal barrier from anoxia\/reoxygenation injury via various cellular mechanisms","volume":"13","author":"Kim","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116628_bb1440","doi-asserted-by":"crossref","first-page":"G983","DOI":"10.1152\/ajpgi.00386.2020","article-title":"Larazotide acetate: a pharmacological peptide approach to tight junction regulation","volume":"320","author":"Slifer","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.intimp.2026.116628_bb1445","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/biomedicines13102483","article-title":"Larazotide acetate protects the intestinal mucosal barrier from anoxia\/Reoxygenation injury via various cellular mechanisms","volume":"13","author":"Kim","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116628_bb1450","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1597","article-title":"The role of STING signaling in central nervous system infection and neuroinflammatory disease","volume":"15","author":"Fritsch","year":"2023","journal-title":"WIREs Mechanisms of Disease"},{"key":"10.1016\/j.intimp.2026.116628_bb1455","doi-asserted-by":"crossref","first-page":"F558","DOI":"10.1152\/ajprenal.00004.2023","article-title":"The protective effect of h151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury","volume":"324","author":"Hu","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.intimp.2026.116628_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103202","article-title":"Development of nitroalkene-based inhibitors to target STING-dependent inflammation","volume":"74","author":"Chang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2026.116628_bb1465","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1038\/s41598-020-64348-y","article-title":"Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells","volume":"10","author":"Wiser","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116628_bb1470","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/iovs.65.8.16","article-title":"H-151, a selective STING inhibitor, has potential as a treatment for neovascular age-related macular degeneration","volume":"65","author":"Tanaka","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2026.116628_bb1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116947","article-title":"Emerging insights into lipocalin-2: unraveling its role in parkinsons disease","volume":"177","author":"Qiu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116628_bb1480","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1073\/pnas.1218497110","article-title":"Reactive astrocytes secrete lcn2 to promote neuron death","volume":"110","author":"Bi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116628_bb1485","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1177\/0271678X20960033","article-title":"Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases","volume":"40","author":"Chokkalla","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2026.116628_bb1490","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1681\/ASN.0000000000000428","article-title":"METTL3-mediated n 6 -Methyladenosine mRNA modification and cGAS-STING pathway activity in kidney fibrosis","volume":"35","author":"Tsai","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2026.116628_bb1495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1717319","article-title":"METTL3 inhibition alleviates neuroinflammation and apoptosis by reducing ETV4 m6A modification","volume":"16","author":"He","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116628_bb1500","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221609","article-title":"Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications","volume":"14","author":"Song","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116628_bb1505","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4103\/NRR.NRR-D-23-01872","article-title":"The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases","volume":"20","author":"Li","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116628_bb1510","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2174\/0115665240263859231018110107","article-title":"METTL14 regulates the m6A modification of TRAF6 to suppress mitochondrial dysfunction and ferroptosis in dopaminergic neurons via the cGAS-STING pathway","volume":"24","author":"Shao","year":"2023","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1515","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/biom15050617","article-title":"The role of N6-Methyladenosine (m6A) RNA modification in the pathogenesis of parkinsons disease","volume":"15","author":"Wang","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116628_bb1520","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1592737","article-title":"ROR\u03b1-activated mitophagy attenuating hypoxic-ischemic encephalopathy via suppression of microglial cGAS-STING axis","volume":"16","author":"Song","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116628_bb1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmccpl.2025.100469","article-title":"MitoQ protects against oxidative stress-induced mitochondrial dysregulation in human cardiomyocytes","volume":"13","author":"Parker","year":"2025","journal-title":"Journal of Molecular and Cellular Cardiology Plus"},{"key":"10.1016\/j.intimp.2026.116628_bb1530","article-title":"A microfluidic model of AQP4 polarization dynamics and fluid transport in the healthy and inflamed human brain: the first step towards glymphatics-on-a-chip","volume":"6","author":"Soden","year":"2022","journal-title":"Advanced Biology"},{"key":"10.1016\/j.intimp.2026.116628_bb1535","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuroscience.2025.11.018","article-title":"Astrocytic aquaporin-4 expression, localization, and polarization: mechanisms and therapeutic potential in neurological diseases","volume":"592","author":"Ma","year":"2026","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2026.116628_bb1540","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.878154","article-title":"Canonical bone morphogenetic protein signaling regulates expression of aquaporin-4 and its anchoring complex in mouse astrocytes","volume":"16","author":"Skauli","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.116628_bb1545","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41420-025-02812-2","article-title":"Inhibition of astrocyte BMP signaling alleviates neuroinflammation in experimental models of parkinsons disease","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.116628_bb1550","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.neuron.2025.10.036","article-title":"Resolving the mysteries of brain clearance and immune surveillance","volume":"113","author":"Kipnis","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.116628_bb1555","doi-asserted-by":"crossref","unstructured":"N. Rosenzweig, R. Dvir-Szternfeld, A. Tsitsou-Kampeli, H. Keren-Shaul, H. Ben-Yehuda, P. Weill-Raynal, L. Cahalon, A. Kertser, K. Baruch, I. Amit, A. Weiner, M. Schwartz, PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model, Nat. Commun. 2019 10:1 10 (2019) 465-. doi:https:\/\/doi.org\/10.1038\/s41467-019-08352-5.","DOI":"10.1038\/s41467-019-08352-5"},{"key":"10.1016\/j.intimp.2026.116628_bb1560","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm.4022","article-title":"PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of alzheimers disease","volume":"22","author":"Baruch","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1565","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/acs.molpharmaceut.4c00160","article-title":"Macrophages and natural killers degrade \u03b1-Synuclein aggregates","volume":"21","author":"Matveyenka","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2026.116628_bb1570","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pneurobio.2019.01.002","article-title":"Chronotherapies for parkinsons disease","volume":"174","author":"Fifel","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"2013","key":"10.1016\/j.intimp.2026.116628_bb1575","first-page":"373","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116628_bb1580","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082092","article-title":"The dynamic relationship between the glymphatic system, aging, memory, and sleep","volume":"11","author":"Voumvourakis","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116628_bb1585","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1559827619867677","article-title":"Cognitive-behavioral therapy for insomnia: an effective and underutilized treatment for insomnia","volume":"13","author":"Rossman","year":"2019","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1590","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s44323-025-00025-5","article-title":"Dual orexin receptor antagonists as promising therapeutics for alzheimers disease","volume":"2","author":"Ragsdale","year":"2025","journal-title":"Npj Biological Timing and Sleep"},{"key":"10.1016\/j.intimp.2026.116628_bb1595","first-page":"1","article-title":"The effectiveness of cognitive behavioral therapy for insomnia (CBT-I) in improving sleep quality: a Meta-analysis of randomized controlled trials","volume":"4","author":"Berry","year":"2021","journal-title":"Journal of Public Health & Environment"},{"key":"10.1016\/j.intimp.2026.116628_bb1600","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2026.108792","article-title":"The effect of dual orexin receptor antagonists on sleep: a systematic review and pairwise meta-analysis","volume":"140","author":"Stefanou","year":"2026","journal-title":"Sleep Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1605","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","article-title":"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial","volume":"405","author":"Vijiaratnam","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.116628_bb1610","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1212\/WNL.98.18_supplement.3068","article-title":"Liraglutide improves non-motor function and activities of daily living in patients with parkinsons disease: a randomized, double-blind, placebo-controlled trial (p9-11.005)","volume":"98","author":"Malatt","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2026.116628_bb1615","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/nu17081303","article-title":"Effects of GLP-1 analogues and agonists on the gut microbiota: a systematic review","volume":"17","author":"Gofron","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116628_bb1620","article-title":"Rebalancing the gut: glucagon-like peptide-1 agonists as a strategy for obesity and metabolic health","volume":"16","author":"Singh","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2026.116628_bb1625","article-title":"cGAS-STING-mediated inflammation and neurodegeneration as a strategy for the treatment of neurodegenerative diseases: role of mtDNA-cGAS-STING in neurodegenerative diseases","volume":"56","author":"Luo","year":"2023","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.intimp.2026.116628_bb1630","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108173","article-title":"Metformin regulates astrocyte reactivity in parkinsons disease and normal aging","volume":"175","author":"Ryu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2026.116628_bb1635","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/cells14141114","article-title":"Therapeutic potential of calcium channel blockers in neuropsychiatric, endocrine and pain disorders","volume":"14","author":"Manzar","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116628_bb1640","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The l-type channel antagonist isradipine is neuroprotective in a mouse model of parkinsons disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116628_bb1645","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/M19-2534","article-title":"Isradipine versus placebo in early parkinson disease: a randomized trial","volume":"172","author":"Simuni","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1650","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116628_bb1655","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbadis.2010.12.022","article-title":"Mitochondrial defect and PGC-1\u03b1 dysfunction in parkin-associated familial parkinsons disease","volume":"1812","author":"Pacelli","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116628_bb1660","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41420-025-02812-2","article-title":"Inhibition of astrocyte BMP signaling alleviates neuroinflammation in experimental models of Parkinson\u2019s disease","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600473X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600473X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:14:31Z","timestamp":1777130071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600473X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":332,"alternative-id":["S156757692600473X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116628","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cGAS-STING-Glymphatic-gut Axis in Parkinson's disease: A proposed self-amplifying triad of Neuroinflammation and therapeutic opportunity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116628"}}